Magic mushrooms take on OCD: new trial tests doses for relief
NCT ID NCT07347405
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 2 times
Summary
This study tests whether psilocybin, the active ingredient in magic mushrooms, can safely help people with obsessive-compulsive disorder (OCD). Thirty adults with moderate to severe OCD who haven't improved with standard treatments will receive either a low, medium, or high dose of whole mushroom in chocolate. The goal is to see if it reduces OCD symptoms and improves quality of life over 12 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSESSIVE-COMPULSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Clinical and Translational Sciences Research Center
RECRUITINGTucson, Arizona, 85724, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single ketamine infusion quiet the obsessive mind?
- Can improv comedy help tame OCD?
- A Two-Year watch: can brain scans and surveys predict depression and anxiety in teens?
- Therapy may let kids with OCD ditch meds for good
- Could gut bacteria hold the key to childhood OCD?
- Can brain recordings unlock better OCD treatment?